Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on June 20, 2013, covering events occurring on June 19, 2013. The filing reports the election of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the election of Dinesh Paliwal to the Board of Directors, effective July 1, 2013. Mr. Paliwal is the Chairman, CEO, and President of Harman International Industries, Incorporated. He has been determined to be independent under NYSE Listing Standards and will serve on the Committee on Directors and Corporate Governance.
Guidance, Outlook, and Compensation
There is no guidance, outlook, or management commentary regarding future financial performance in this filing. Regarding compensation, Mr. Paliwal will receive the Company's standard arrangement for non-employee directors, including:
- An annual retainer of $90,000.
- An annual award of deferred share units valued at $160,000 on the date of grant.
- A pro rata portion of the 2013 annual deferred share unit award upon joining the Board.
The filing states there are no related party transactions between the Company and Mr. Paliwal.
Investor Verification Checklist
- Verify the effective date of Mr. Paliwal's board membership (July 1, 2013).
- Confirm the specific committee assignments for the new director.
- Review the attached press release (Exhibit 99.1) for additional biographical details.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.